| 1 | [SID49645338] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 2 | [SID49645338] | Active | Potency | 56.2341 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 3 | [SID49645338] | Active | IC50 | 178.83 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens [AID624330, Type: confirmatory] | RACGAP1 gene product [Homo sapiens] [gi:21361397] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | IC50 | 178.83 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens | | AID | 624330 | | BioAssay type | confirmatory | | Target | RACGAP1 gene product [Homo sapiens] [gi:21361397] | | PubMed | | | Data Table |  |
|
| 4 | [SID49645338] | Active | | | Specificity screen against KCNQ1/KCNE1 for identification of compounds that inhibit KCNQ1 potassium channels [AID652147, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Specificity screen against KCNQ1/KCNE1 for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 652147 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 5 | [SID49645338] | Active | | | Validation for compounds that inhibit KCNQ1 potassium channels on automated electrophysiology assay [AID624120, Type: other] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Validation for compounds that inhibit KCNQ1 potassium channels on automated electrophysiology assay | | AID | 624120 | | BioAssay type | other | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 6 | [SID49645338] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels [AID2642, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 2642 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 7 | [SID49645338] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624381, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624381 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 8 | [SID49645338] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624381, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624381 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 9 | [SID49645338] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 10 | [SID49645338] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 11 | [SID49645338] | Active | | | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels [AID651746, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 651746 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 12 | [SID49645338] | Active | | | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels [AID651746, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 651746 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 13 | [SID49645338] | Active | | | Validation (re-confirmation) assay for identification of compounds that inhibit KCNQ1 potassium channels [AID588353, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Validation (re-confirmation) assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 588353 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 14 | [SID49645338] | Active | | | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput screening assay to identify agonists of the mu 1 opioid receptor (OPRM1) [AID624380, Type: screening] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput screening assay to identify agonists of the mu 1 opioid receptor (OPRM1) | | AID | 624380 | | BioAssay type | screening | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 15 | [SID49645338] | Active | | | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput screening assay to identify agonists of the mu 1 opioid receptor (OPRM1) [AID624380, Type: screening] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput screening assay to identify agonists of the mu 1 opioid receptor (OPRM1) | | AID | 624380 | | BioAssay type | screening | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 16 | [SID49645338] | Active | | | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput screening assay to identify agonists of the mu 1 opioid receptor (OPRM1) [AID624380, Type: screening] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput screening assay to identify agonists of the mu 1 opioid receptor (OPRM1) | | AID | 624380 | | BioAssay type | screening | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 17 | [SID49645338] | Active | | | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput screening assay to identify agonists of the mu 1 opioid receptor (OPRM1) [AID624380, Type: screening] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Active | | BioAssay | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput screening assay to identify agonists of the mu 1 opioid receptor (OPRM1) | | AID | 624380 | | BioAssay type | screening | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 18 | [SID49645338] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 19 | [SID49645338] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 20 | [SID49645338] | Inactive | Potency | 0.0141 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | Potency | 0.0141 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 21 | [SID49645338] | Inactive | Potency | 7.9433 | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | Potency | 7.9433 [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 22 | [SID49645338] | Inactive | Potency | | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624288, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624288 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 23 | [SID49645338] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). [AID1861, Type: screening] | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). | | AID | 1861 | | BioAssay type | screening | | Target | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] | | PubMed | | | Data Table |  |
|
| 24 | [SID49645338] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). [AID1861, Type: screening] | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). | | AID | 1861 | | BioAssay type | screening | | Target | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] | | PubMed | | | Data Table |  |
|
| 25 | [SID49645338] | Inactive | IC50 | | Image-Based HTS for Selective Antagonists of GPR35 [AID2058, Type: confirmatory] | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Image-Based HTS for Selective Antagonists of GPR35 | | AID | 2058 | | BioAssay type | confirmatory | | Target | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] | | PubMed | | | Data Table |  |
|
| 26 | [SID49645338] | Inactive | IC50 | | Image-Based HTS for Selective Antagonists of GPR35 [AID2058, Type: confirmatory] | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Image-Based HTS for Selective Antagonists of GPR35 | | AID | 2058 | | BioAssay type | confirmatory | | Target | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] | | PubMed | | | Data Table |  |
|
| 27 | [SID49645338] | Inactive | IC50 | | Image-Based HTS for Selective Antagonists of GPR35 [AID2058, Type: confirmatory] | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Image-Based HTS for Selective Antagonists of GPR35 | | AID | 2058 | | BioAssay type | confirmatory | | Target | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] | | PubMed | | | Data Table |  |
|
| 28 | [SID49645338] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 29 | [SID49645338] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 30 | [SID49645338] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 31 | [SID49645338] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 32 | [SID49645338] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 33 | [SID49645338] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 34 | [SID49645338] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 35 | [SID49645338] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 36 | [SID49645338] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 37 | [SID49645338] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 38 | [SID49645338] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 39 | [SID49645338] | Inactive | | | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) [AID1789, Type: screening] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1789 | | BioAssay type | screening | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 40 | [SID49645338] | Inactive | | | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) [AID1789, Type: screening] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1789 | | BioAssay type | screening | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 41 | [SID49645338] | Inactive | | | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) [AID1789, Type: screening] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1789 | | BioAssay type | screening | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 42 | [SID49645338] | Inactive | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 43 | [SID49645338] | Inactive | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 44 | [SID49645338] | Inactive | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 45 | [SID49645338] | Inactive | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 46 | [SID49645338] | Inactive | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 47 | [SID49645338] | Inactive | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 48 | [SID49645338] | Inactive | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) [AID493087, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) | | AID | 493087 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 49 | [SID49645338] | Inactive | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) [AID434962, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) | | AID | 434962 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 50 | [SID49645338] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49645338 | | CID | 17367617 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|